HTG Molecular Diagnostics, Inc.

HTGMQOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$221

P/E Ratio—

52W High$0.0001

52W Low$0.0001

Avg Volume34

Open$0.00

Beta2.76

Earnings Financials Revenue

HTG Molecular Diagnostics, Inc. (HTGMQ) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

HTGMQ · earnings · updated Jun 9, 2026

Latest Earnings

Q2 FY2023Report Date: Apr 19, 2023

EPS Actual

-$4.47

Est. -$1.84 · -143.1%

Revenue

$0.00B

Fiscal Period

Q2 FY2023

FY ends December

Report Date

Apr 19, 2023

After Market Close

▼ Miss EPS

HTGMQ reports quarterly as a OTC-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

$1.20

Rev. $3.50B

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.$1.20

Rev. Est.$3.50B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Aug 14, 2026	-$9.21	—	—	—	$0.00B	—
◌ Q2 FY2026	May 29, 2026	-$11.80	—	—	—	$0.00B	—
◌ Q2 FY2026	Apr 1, 2026	—	—	—	—	—	—
◌ Q4 FY2024	Dec 31, 2024	—	—	—	—	—	—
◌ Q4 FY2024	Dec 23, 2024	—	—	—	—	—	—
◌ Q3 FY2024	Sep 27, 2024	-$2.16	—	—	—	$0.00B	—
◌ Q2 FY2024	Jun 28, 2024	-$2.28	—	—	—	$0.00B	—
◌ Q1 FY2024	Feb 19, 2024	-$0.68	—	—	—	$0.00B	—

Q3 FY2026

Aug 14, 2026

EPS Actual

—

EPS Est.

-$9.21

EPS Surpr.

—

Revenue

—

Q2 FY2026

May 29, 2026

EPS Actual

—

EPS Est.

-$11.80

EPS Surpr.

—

Revenue

—

Q2 FY2026

Apr 1, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2024

Dec 31, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2024

Dec 23, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Sep 27, 2024

EPS Actual

—

EPS Est.

-$2.16

EPS Surpr.

—

Revenue

—

Q2 FY2024

Jun 28, 2024

EPS Actual

—

EPS Est.

-$2.28

EPS Surpr.

—

Revenue

—

Q1 FY2024

Feb 19, 2024

EPS Actual

—

EPS Est.

-$0.68

EPS Surpr.

—

Revenue

—

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q3 FY2030	$-2.16	$-2.16	$-2.16	1
Q2 FY2030	$-2.16	$-2.16	$-2.16	1
Q1 FY2030	$-2.16	$-2.16	$-2.16	1
Q4 FY2029	$-2.16	$-2.16	$-2.16	1
Q3 FY2029	$-2.16	$-2.16	$-2.16	1
Q2 FY2029	$-2.16	$-2.16	$-2.16	1

Revenue Estimates

Period	Low	Consensus	High	# Analysts
Q3 FY2030	$0.0B	$0.0B	$0.0B	1
Q2 FY2030	$0.0B	$0.0B	$0.0B	1
Q1 FY2030	$0.0B	$0.0B	$0.0B	1
Q4 FY2029	$0.0B	$0.0B	$0.0B	1
Q3 FY2029	$0.0B	$0.0B	$0.0B	1
Q2 FY2029	$0.0B	$0.0B	$0.0B	1

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▼ Q2 FY2023	Apr 19, 2023	-143.1%	$0.25	$0.21	-14.40%
▼ Q2 FY2023	Apr 8, 2023	-24.1%	$0.16	$0.15	-2.12%

Q2 FY2023-14.40%

Report Date

Apr 19, 2023

EPS Beat/Miss

-143.1%

Price Before

$0.25

Price After

$0.21

Q2 FY2023-2.12%

Report Date

Apr 8, 2023

EPS Beat/Miss

-24.1%

Price Before

$0.16

Price After

$0.15

Avg Miss Reaction-8.26%

Beat Rate0 / 2 quarters

Largest Move-14.40% (Q2 FY2023)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

HTG Molecular Diagnostics, Inc. (HTGMQ) most recently reported earnings on April 19, 2023 for Q2 FY2023, posting EPS of $-4.47 — missing the analyst consensus of $-1.84 by -143.1%. The next HTGMQ earnings date is expected around September 1, 2026.

Each quarter, investors track HTGMQ earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HTGMQ revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

HTGMQ's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

HTGMQ earnings · 5 questions

HTG Molecular Diagnostics, Inc.'s next earnings report is expected around September 1, 2026. HTGMQ typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HTGMQ historically reports after market close (AMC).

HTGMQ earnings datewhen is HTGMQ earningsHTGMQ next earnings datewhen does HTGMQ report earningsHTGMQ earnings calendar

▸ Source: FMP · HTG Molecular Diagnostics, Inc. SEC filings · US GAAP · HTG Molecular Diagnostics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026